Venture capital firm based in London, UK
Barocal raises £7.4m to commercialise refrigerant‑free solid‑state cooling for data centres. Read more
Hypervision Surgical raises £17m to reduce surgical leaks with hyperspectral imaging. Read more
Alesi Surgical secures £7m to remove surgical smoke using electrostatic precipitation. Read more
Oxa raises £77m to commercialise autonomous vehicle software for industrial sites. Read more
Artios lands £87.4m to advance new targeted treatments for hard-to-treat cancers. Read more
Lumai secures £7,740,000 to boost AI performance and slash energy costs—paving the way for smarter, more efficient technology. Read more
Oxford's Diffblue grabs a £1M Innovate UK grant, paving the way for AI-powered coding efficiency. Invest in the future of software. Read more
Alesi Surgical shakes up the operating room with a £5 million boost to eliminate surgical smoke and elevate patient safety, all while eyeing the competitive U.S. market. Read more
Mission Therapeutics secures £25.2M in funding to accelerate development of lead drug candidates targeting dysfunctional mitochondria and tackling diseases like Parkinson's Disease and heart failure. Read more
| Healthtech | 46.7% |
| SaaS | 20.0% |
| AI | 6.7% |
| Biotech | 6.7% |
| Energy | 6.7% |
| Greentech | 6.7% |
| Mobility | 6.7% |